Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.300, 2001-01, pp. : 7-7
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Moxifloxacin superior in AECB?
Inpharma, Vol. 1, Iss. 1432-1433, 2004-01 ,pp. :
Access to resources
Recommend
Moxifloxacin: faster relief of symptoms in AECB?
Inpharma, Vol. 1, Iss. 1263, 2000-01 ,pp. :
QOL with new triptan no better than with US market leader?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 302, 2001-01 ,pp. :
Substantial delays in US infant vaccinations: better late than never?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 474, 2005-01 ,pp. :
Substantial delays in US infant vaccinations: better late than never?
Inpharma, Vol. 1, Iss. 1479, 2005-01 ,pp. :